Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial

2013251 citationsJournal Article

Authors

Good health and well-being

Published in: Ophthalmology

Volume 120, Issue 11, pp. 2300-2309

Field-Weighted Citation Impact: 28.34